Getein Biotech Inc - Asset Resilience Ratio

Latest as of March 2026: 29.77%

Getein Biotech Inc (603387) has an Asset Resilience Ratio of 29.77% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 603387 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.10 Billion

≈ $161.12 Million USD Cash + Short-term Investments

Total Assets

CN¥3.70 Billion

≈ $541.26 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Getein Biotech Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Getein Biotech Inc.

Liquid Assets Composition Over Time

This chart breaks down Getein Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Getein Biotech Inc total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.10 Billion	29.77%
Total Liquid Assets	CN¥1.10 Billion	29.77%

Asset Resilience Insights

Very High Liquidity: Getein Biotech Inc maintains exceptional liquid asset reserves at 29.77% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Getein Biotech Inc Industry Peers by Asset Resilience Ratio

Compare Getein Biotech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medtronic plc SA:MDTC34	Medical Devices	7.82%
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Medartis Holding AG SW:MED	Medical Devices	0.00%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Beijing Chunlizhengda Medical Instruments Co Ltd SHG:688236	Medical Devices	25.01%
Mediantechn PA:ALMDT	Medical Devices	0.45%

Annual Asset Resilience Ratio for Getein Biotech Inc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Getein Biotech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	24.30%	CN¥912.63 Million ≈ $133.55 Million	CN¥3.76 Billion ≈ $549.61 Million	+6.80pp
2024-12-31	17.50%	CN¥648.88 Million ≈ $94.95 Million	CN¥3.71 Billion ≈ $542.51 Million	+5.52pp
2023-12-31	11.98%	CN¥451.91 Million ≈ $66.13 Million	CN¥3.77 Billion ≈ $551.91 Million	-1.92pp
2022-12-31	13.90%	CN¥511.14 Million ≈ $74.80 Million	CN¥3.68 Billion ≈ $538.12 Million	-5.63pp
2021-12-31	19.52%	CN¥612.68 Million ≈ $89.65 Million	CN¥3.14 Billion ≈ $459.18 Million	-2.51pp
2020-12-31	22.03%	CN¥594.92 Million ≈ $87.06 Million	CN¥2.70 Billion ≈ $395.09 Million	-1.24pp
2019-12-31	23.28%	CN¥467.36 Million ≈ $68.39 Million	CN¥2.01 Billion ≈ $293.78 Million	-26.79pp
2017-12-31	50.07%	CN¥634.14 Million ≈ $92.79 Million	CN¥1.27 Billion ≈ $185.34 Million	+11.58pp
2016-12-31	38.49%	CN¥167.08 Million ≈ $24.45 Million	CN¥434.09 Million ≈ $63.52 Million	--

pp = percentage points

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$699.08 Million

CN¥4.78 Billion CNY

Market Cap Rank

#10666 Global

#2910 in China

Share Price

CN¥9.42

Change (1 day)

-0.63%

52-Week Range

CN¥7.52 - CN¥10.65

All Time High

CN¥21.49